Pathway-Focused Gene Expression Panels Validated for Real-time PCR
News Apr 08, 2010
Fluidigm Corporation and SABiosciences have announced that they have teamed up to create over 100 pathway-focused gene expression panels validated for real-time PCR analysis on the Fluidigm BioMark™ System for Genetic Analysis. These kits are named the RT² Profiler™ PCR Arrays for the Fluidigm BioMark system.
These gene expression assays are specifically designed for the workflow of Fluidigm's integrated fluidic circuits (IFCs) and the BioMark system. Each reagent kit includes pre-aliquoted reagents and primers needed for synthesizing first-strand cDNA ready for preamplification and pathway-focused analysis. PCR Arrays contain enough reagent to run five 96.96 Dynamic Array chips (customized panels are also available). PCR arrays come in a 96-well format making either 96.96 or 48.48 Dynamic Array™ chip set up fast and simple.
"SABiosciences solutions focusing on the analysis of pathways with real time assay panel kits are an excellent fit to our products. The kits include 96 cataloged gene expression assays, targeting genes in signal transduction, biological process, and disease-related pathways. The kits can provide a great solution for customers looking to lower start up costs, or that need pre-validated pathways for a new project," said Mike Lee, Fluidigm's Senior Director of Marketing.
"SABiosciences offers real-time PCR Arrays that are the most reliable and sensitive gene expression profiling technology for analyzing a focused panel of genes and now gain the additional benefits of Fluidigm's genetic analysis technology," said Shankar Sellappan, Ph.D., SABiosciences PCR Array Product Manager.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
SCRaMbLE Speeds Up Yeast EvolutionNews
Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).READ MORE
Artificial Cellular Compartments BuiltNews
How to install new capabilities in cells without interfering with their metabolic processes? A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München have altered mammalian cells in such a way that they formed artificial compartments in which sequestered reactions could take place, allowing the detection of cells deep in the tissue and also their manipulation with magnetic fields.READ MORE